Fig. 3
Kaplan–Meier Estimates of study end points among patients who with elevated hs-cTnI or normal hs-cTnI after further excluding patients have received chemoradiotherapy
Fig. 3 | Cardio-Oncology
Kaplan–Meier Estimates of study end points among patients who with elevated hs-cTnI or normal hs-cTnI after further excluding patients have received chemoradiotherapy